Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRELUDE: Truvada PrEP Implementation in NSW
NCT02206555Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Nov 2014; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02206555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206555.